Global Cord Blood
CORBF
#9374
Rank
S$0.18 B
Marketcap
S$1.35
Share price
0.00%
Change (1 day)
38.81%
Change (1 year)
Categories

Earnings for Global Cord Blood (CORBF)

Earnings in 2022 (TTM): S$0.12 Billion

According to Global Cord Blood's latest financial reports the company's current earnings are S$0.19 Billion. In 2021 the company made an earning of S$0.12 Billion, an increase over its 2020 earnings that were of S$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Global Cord Blood from 2008 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) S$0.12 B4.77%
2021 S$0.12 B15.78%
2020 S$0.10 B10.11%
2019 S$96.24 M46.83%
2018 S$65.54 M5.31%
2017 S$62.24 M22.57%
2016 S$50.77 M-3.68%
2015 S$52.71 M-6.8%
2014 S$56.56 M8.79%
2013 S$51.99 M19.85%
2012 S$43.38 M39.37%
2011 S$31.12 M34.18%
2010 S$23.19 M124.91%
2009 S$10.31 M-563.02%
2008 -S$2.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
RadNet
RDNT
S$0.13 B 11.79%๐Ÿ‡บ๐Ÿ‡ธ USA
National Healthcare
NHC
S$0.24 B 97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$42.42 Million-134.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Cryo-Cell International
CCEL
-S$1.58 Million-101.28%๐Ÿ‡บ๐Ÿ‡ธ USA